Bipolar Disorder News and Research RSS Feed - Bipolar Disorder News and Research

Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. Symptoms of bipolar disorder are severe. They are different from the normal ups and downs that everyone goes through from time to time. Bipolar disorder symptoms can result in damaged relationships, poor job or school performance, and even suicide. But bipolar disorder can be treated, and people with this illness can lead full and productive lives.
Poor sleep linked to negative mood in women with bipolar disorder

Poor sleep linked to negative mood in women with bipolar disorder

Poor sleep is associated with negative mood in women with bipolar disorder, according to researchers at Penn State College of Medicine and University of Michigan Medical School. [More]
Alexza updates, amends ADASUVE (Staccato loxapine) commercial partnerships with Ferrer and Teva

Alexza updates, amends ADASUVE (Staccato loxapine) commercial partnerships with Ferrer and Teva

Alexza Pharmaceuticals, Inc. today announced that it has updated and amended its ADASUVE (Staccato loxapine) commercial partnerships with Grupo Ferrer Internacional, S.A. and Teva Pharmaceutical Industries Ltd. Ferrer is Alexza's commercial partner for ADASUVE in the European Union, Latin America, the Commonwealth of Independent States and other countries in Europe. [More]
Study highlights the importance of nutrition for maintaining mental health

Study highlights the importance of nutrition for maintaining mental health

An international study involving the Faculty of Medicine and Dentistry of the University of Valencia, recently published in 'The Lancet Psychiatry', highlights the importance of nutrition for maintaining mental health. Lecturer of Psychiatry Vicent Balanzá has participated in this study. [More]
Study suggests direct biophysical link between chronic pain, depression and anxiety

Study suggests direct biophysical link between chronic pain, depression and anxiety

Brain inflammation caused by chronic nerve pain alters activity in regions that regulate mood and motivation, suggesting for the first time that a direct biophysical link exists between long-term pain and the depression, anxiety and substance abuse seen in more than half of these patients, UC Irvine and UCLA researchers report. [More]
Manic symptoms during depression warn of polarity switch

Manic symptoms during depression warn of polarity switch

Concomitant manic symptoms and panic attacks are the strongest predictors of an impending switch to mania among patients with bipolar disorder who are currently depressed, shows analysis of the STEP-BD study. [More]
Addiction history indicates bipolar conversion risk from precursor disorders

Addiction history indicates bipolar conversion risk from precursor disorders

Substance use and the presence of subthreshold affective symptoms may predict future bipolar disorder in young people with precursor conditions such as depression, research suggests. [More]
Scientists reveal how disruption of DISC1 gene involved in mental illness affects the brain

Scientists reveal how disruption of DISC1 gene involved in mental illness affects the brain

Scientists have for the first time shown how the disruption of a key gene involved in mental illness impacts on the brain. [More]
Emotion regulation distinguishes unipolar and bipolar depression

Emotion regulation distinguishes unipolar and bipolar depression

Patients with bipolar disorder regulate their emotions differently from those with major depressive disorder in both depressed and remitted states, a study shows. [More]
Brain & Behavior Research Foundation to award grants to 40 scientists for research into mental illness

Brain & Behavior Research Foundation to award grants to 40 scientists for research into mental illness

The Brain & Behavior Research Foundation today announced its 2015 Independent Investigator Grants which will award $3.9 million in funding to 40 mid-career scientists from 30 institutions in 16 countries. [More]
Hallucinations, delusions associated with psychiatric disorders seldom trigger violent crimes

Hallucinations, delusions associated with psychiatric disorders seldom trigger violent crimes

Mass shootings at the hands of unhinged loners - such as those in Aurora, Colorado; Santa Barbara, California, and Newtown, Connecticut - perpetuate a commonly held belief that mental illness triggers violent crimes. [More]
Study finds extremely high levels of cardiovascular risk factors in people with psychosis

Study finds extremely high levels of cardiovascular risk factors in people with psychosis

Extremely high levels of cardiovascular risk factors have been found in people with established psychosis, with central obesity evident in over 80 per cent of participants, in a study by researchers from the NIHR Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and King's College London. [More]
Non-suicidal self-injury common among Iraq and Afghanistan veterans

Non-suicidal self-injury common among Iraq and Afghanistan veterans

Non-suicidal self-injury--that is, purposefully hurting oneself without conscious suicidal intent--is relatively common among Iraq and Afghanistan veterans, according to a study published online April 1, 2015, in Psychiatry Research. [More]
Study finds link between PTSD and accelerated aging

Study finds link between PTSD and accelerated aging

In recent years, public health concerns about post-traumatic stress disorder (PTSD) have risen significantly, driven in part by affected military veterans returning from conflicts in the Middle East and elsewhere. PTSD is associated with number of psychological maladies, among them chronic depression, anger, insomnia, eating disorders and substance abuse. [More]
Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics, Inc. today announced business and financial results for the first quarter ended March 31, 2015. [More]

E-learning can provide efficient approach to training psychotherapists in new evidence-based treatments

Employing online training programs to teach psychotherapists how to use newer evidence-based treatments can be as successful as in-person instruction, according to a new RAND Corporation study. [More]
New study shows that depression can make your brain go 'fuzzy'

New study shows that depression can make your brain go 'fuzzy'

People with depression or bipolar disorder often feel their thinking ability has gotten "fuzzy", or less sharp than before their symptoms began. Now, researchers have shown in a very large study that effect is indeed real - and rooted in brain activity differences that show up on advanced brain scans. [More]

Bipolar disorder impacts life expectancy in the young

Research indicates that patients with bipolar disorder have a decreased life expectancy, with this being particularly pronounced in younger patients. [More]

Clinical features identified to distinguish bipolar I disorder from MDD

Researchers have identified seven clinical features that could help distinguish patients with bipolar disorder from those with major depressive disorder. [More]
New Tel Aviv University study may pave way for personalized bipolar disorder treatment

New Tel Aviv University study may pave way for personalized bipolar disorder treatment

Rapidly swinging from extremes of joy and energy to sadness, fatigue, and confusion, bipolar disorder (BD) patients feel desperate and largely alone in the world. And according to the National Institutes of Health, between 25-50 percent of the roughly 3% of Americans living with BD attempt suicide at least once. [More]
Tal Medical raises $14 million funding round from new and existing investors

Tal Medical raises $14 million funding round from new and existing investors

Tal Medical, a clinical-stage medical device company developing a new treatment for depression and other psychiatric disorders, today announced a $14 million funding round from existing investor PureTech, a new institutional investor, and several prominent individual investors. [More]
Advertisement